Related Experiment Videos
Epstein-Barr virus antibodies in children with atopic disease
Insights
Children with atopic diseases, including asthma and atopic dermatitis, show higher Epstein-Barr virus (EBV) antibody titers. This suggests a potential role for EBV in the development of allergic conditions in children.
Area of Science:
- Immunology
- Pediatrics
- Virology
Background:
- Atopic diseases, such as asthma and atopic dermatitis, are common in childhood.
- The role of viral infections in the development or exacerbation of atopic diseases is not fully understood.
- Epstein-Barr virus (EBV) is a common human herpesvirus known to affect B-cells.
Purpose of the Study:
- To investigate the prevalence and antibody titers of human herpetoviruses, rubella, and mumps in children with atopic diseases compared to controls.
- To specifically examine the association between Epstein-Barr virus (EBV) antibody levels and atopic conditions in children.
Main Methods:
- Antibody titers to human herpetoviruses, rubella, and mumps were measured.
- A cohort of 98 children with atopic diseases was compared to 55 nonatopic control children.
- Statistical analysis was performed to identify significant differences between the groups.
Main Results:
- Significantly higher titers of Epstein-Barr virus (EBV) antibodies were observed in children with atopic diseases across all age groups.
- Elevated EBV antibody levels were noted in children with both asthma and atopic dermatitis.
- While seropositivity for EBV was slightly higher in atopic children, this difference was not statistically significant.
Conclusions:
- Epstein-Barr virus (EBV) infection may play a role in the pathogenesis of atopic diseases in children.
- The findings suggest EBV's potential involvement in IgE hyperproduction and the development of allergic conditions.
- Further research is warranted to explore the pathogenic mechanisms linking EBV to atopic disease.
Abstract:
The prevalence and titers of antibodies to human herpetoviruses as well as rubella and mumps viruses were determined in 98 children with atopic diseases and in 55 nonatopic control children. The only significant difference between the two groups was found as regards Epstein-Barr virus (EBV) antibodies, which were found in higher titers in atopic children of all ages. Increased levels of EBV antibodies were found both in children with asthma and atopic dermatitis. The frequency of seropositivity for EBV was slightly higher in atopics than in controls in all age-groups, but the differences observed were not statistically significant. The possibility that EBV, which is a B-cell mitogen, has a pathogenic role in the hyperproduction of IgE and development of atopic disease, should be considered.